Navigation Links
ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes
Date:12/16/2008

EVOTECH(TM) System Offers Healthcare Workers Consistent Cleaning

and Complete Confidence

IRVINE, Calif., Dec. 16 /PRNewswire/ -- Advanced Sterilization Products (ASP) is pleased to announce the availability of the EVOTECH(TM) Endoscope Cleaner and Reprocessor, the first commercially available system to eliminate labor-intensive manual cleaning of endoscopes. The results of the EVOTECH(TM) System establish a consistently high standard of automated endoscope cleaning and high-level disinfection that is comparable to professional society guidelines for manual cleaning.

By removing the need to manually clean, the EVOTECH(TM) System eliminates the risk of human variation in endoscope cleaning. In addition, the EVOTECH(TM) System's 33-minute or less reprocessing cycle time provides fast turn-around of instrumentation and enables healthcare workers to spend more time completing patient-related activities.

"With the EVOTECH(TM) System's exceptional automation and technology, you can be confident that endoscopes are reprocessed safely and consistently," said Karen Borg, Worldwide Vice President of Marketing at ASP. "The EVOTECH(TM) System is a trailblazer and one more example of how ASP is continually delivering innovative infection prevention solutions that meet our customers' needs."

The EVOTECH(TM) System features:

  • Integrated Minimum Effective Concentration (MEC) monitoring that eliminates the need to handle high-level disinfectant, limiting the chance of staff exposure.
  • Automated leak detection at the beginning and end of the cycle, which helps ensure endoscope integrity.
  • Built-in alcohol flush that complies with SGNA recommendations to promote drying of endoscopes.
  • Single-use high-level disinfection using glutaraldehyde-free CIDEX(R) OPA Concentrate Solution.
  • Dual, independent basins that offer cleaning and reprocessing in 33 minutes or less.
  • Convenient hands-free operation.
  • Audible alarm can be turned on to alert of cycle completion.

The EVOTECH(TM) System is indicated for use with high-level disinfectant CIDEX(R) OPA Concentrate Solution and an enzymatic detergent (CIDEZYME(R) GI) to achieve cleaning and high-level disinfection of heat sensitive (>60 degrees Celsius) semi-critical endoscopes. Manual cleaning of medical devices (endoscopes) is not required prior to placement in the EVOTECH(TM) System when selecting those cycles that contain a wash stage. Manual cleaning of medical devices (endoscopes) is required when selecting the Disinfect only or Disinfect/Alcohol Flush Cycle.

For more information about the EVOTECH(TM) System, please visit www.evotechecr.com or call 1-888-783-7723.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health and safety for those who matter most. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives.

www.evotechecr.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
2. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
3. Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
4. Bioamber announces worlds first bio-based succinic acid plant: helping to reduce dependence on fossil fuels
5. OmegaGenesis Announces Angiogenesis Application Collaboration
6. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
7. Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury
8. Osteotech Announces Stock Repurchase Program
9. Martek Announces Fourth Quarter and FY 2008 Financial Results
10. Helix BioPharma Announces Q1 2009 Financial Results
11. Neogen Announces New Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Market Research Future has a half cooked research report on Global ... rapidly and expected to reach USD 450 Million by the end ... ... been assessed as a swiftly growing market and expected that the ... future. There has been a tremendous growth in the prevalence of ...
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research and ... has announced the addition ... - Material, Application - Forecast to 2025" report to ... The report provides a detailed analysis on current ... Market forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... Bethesda, MD (PRWEB) , ... January 18, 2017 ... ... for the National Institutes of Health (NIH) to update its Data Sharing Policy. ... a “scoreable” element of grant applications subject to the existing policy. AMIA recommended ...
Breaking Biology Technology:
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/8/2016)... -- Singulex, Inc., the leader in Next Generation Immunodiagnostics powered ... and supply agreement with Thermo Fisher Scientific, the world ... to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker which, ... diagnose systemic bacterial infection and sepsis and in ... assessing the risk of critically ill patients for progression ...
Breaking Biology News(10 mins):